INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsLowNeutral
Announced Tue, 20 Jan · 18:34 IST

Intimation of Schedule of Analysts / Institutional Investors Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Board & Shareholder Meetings View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories Limited has informed the stock exchanges about its upcoming schedule of meetings with analysts and institutional investors, as required under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. This is a routine compliance filing to disclose in advance when company management will be interacting with the investment community. The specific dates, venues, and participants of these meetings are typically detailed in the attached annexure to the filing. The company has not disclosed any material new information or business developments in this intimation itself.

Likely market impact

This is a standard regulatory disclosure with no direct impact on share price or business outlook. Investors should watch for any presentations or disclosures made during these meetings, which could provide insights into the company's strategy, financials, or outlook.